NOS2 and obesity due to melanocortin 4 receptor deficiency: Supporting the role of iNOS signaling in the development of impaired lymphatic function and the pathogenesis of obesity, utilization of the selective iNOS inhibitor 1400W was able to improve lymphatic contractile function in obese mice (Torrisi et al., 2016).